{
    "organizations": [],
    "uuid": "61f85e00be1d787969af81ce64327decc69a46ae",
    "author": "Joseph Walker",
    "url": "https://www.wsj.com/articles/trump-policy-change-is-a-win-for-drugmakers-1521716400",
    "ord_in_thread": 0,
    "title": "Trump Policy Change Is a Win for Drugmakers",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "The Trump administration has issued a policy change that could drive up prices of certain biologic drugs, implementing a new industry-backed measure that overturns existing regulation that promoted lower prices.\nThe move came after months of intense lobbying last year by pharmaceutical companies to overturn an Obama administration policy, introduced in 2015, that rewarded doctors with larger profits if they used the lowest-priced biosimilars, which are generic-like copies of brand-name biologic drugs. The rationale was that... ",
    "published": "2018-03-22T14:00:00.000+02:00",
    "crawled": "2018-03-22T14:04:06.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "trump",
        "administration",
        "issued",
        "policy",
        "change",
        "could",
        "drive",
        "price",
        "certain",
        "biologic",
        "drug",
        "implementing",
        "new",
        "measure",
        "overturn",
        "existing",
        "regulation",
        "promoted",
        "lower",
        "price",
        "move",
        "came",
        "month",
        "intense",
        "lobbying",
        "last",
        "year",
        "pharmaceutical",
        "company",
        "overturn",
        "obama",
        "administration",
        "policy",
        "introduced",
        "rewarded",
        "doctor",
        "larger",
        "profit",
        "used",
        "biosimilars",
        "copy",
        "biologic",
        "drug",
        "rationale"
    ]
}